Improving the diagnosis and treatment of patients with myelodysplastic syndromes through a performance improvement initiative
|
Jan 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
microRNAs in myelodysplastic syndromes: How much do we know and not know?
|
Mar 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes
|
Feb 2014
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Comparison of 24-month outcomes in chelated and non-chelated lower-risk patients with myelodysplastic syndromes in a prospective registry
|
Nov 2013
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes
|
Jan 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Impact of tobacco usage on disease outcome in myelodysplastic syndromes
|
Apr 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Improving the prognostic assessment of myelodysplastic syndromes by understanding the biology of the disease
|
Jul 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure
|
Oct 2014
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Molecular genetics in myelodysplastic syndromes
|
Sep 2012
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Change of prognosis of patients with myelodysplastic syndromes during the last 30 years
|
Apr 2015
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|